EDGAR·FLOW

MEDIFAST INC — Form 10-Q

Filed August 3, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 5/100
What the filing says
CEO Nicholas M. Johnson and CFO James P. Maloney certified the June 30, 2026 quarterly report on Form 10-Q, attesting that financial statements fairly present the company's condition and operations, disclosure controls are effective, and no material weaknesses in internal controls were identified. The certifications are standard Rule 13a-14(a) and Section 906 SOX compliance documents dated August 3, 2026.
Why this rating

Routine quarterly SOX certifications; boilerplate disclosure requirement with no new operational, financial, or strategic information disclosed.

View original filing on SEC.gov ↗ MED · stock on Yahoo Finance ↗

See more from August 3, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.